SPRINT Investigation (Systolic Blood Pressure Intervention Trial)




Initial Inquiry for Patient Enrollment

Healthcare provider's name (required)

Select one of the following that best describes you (required)

 Patient referring myself for the SPRINT Trial Healthcare provider referring my patient

Your Contact Information:
Note: this information will only be shared with the research coordinators of the SPRINT Investigation. Your contact information will not be stored for any purpose other than that which is associated with the clinical investigation.

Your Email (required)

Your telephone number (required)

Patients must meet the following inclusion/exclusion criteria:

Inclusion Criteria:
1. at least 55 years or older

2. systolic blood pressure range as follows:
a. SBP 130-180 mm Hg on 0-1 antihypertensive medications
b. SBP 130-170 mm Hg on up to 2 antihypertensive medications
c. SBP 130 - 160 mm Hg on up to 3 antihypertensive medications

Exclusion Criteria:
1. diabetes mellitus, defined as fasting glucose documented to be greater than or equal to 126 mg/dl during the past 12 months, as well as a history of diagnosed diabetes and/or current treatment for diabetes

2. history of a stroke (without carotid endarterectomy or stenting)

3. diagnosis of polycystic kidney disease

4. eGFR < 25 ml/min/1.73m2 or end-stage renal disease


Share